(Q35072666)

6 August 2017

Translational science by public biotechnology companies in the IPO "class of 2000": the impact of technological maturity (English)

1 reference

6 August 2017

0 references

Laura McNamee

1

1 reference

PubMed ID

24358154

6 August 2017

Fred Ledley

series ordinal

2

1 reference

PubMed ID

24358154

6 August 2017

language of work or name

English

0 references

publication date

16 December 2013

1 reference

6 August 2017

1 reference

6 August 2017

8

1 reference

6 August 2017

12

1 reference

6 August 2017

e82195

1 reference

Creative Commons Attribution 4.0 International

6 August 2017

start time

16 December 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Pharmacogenomics in clinical practice and drug development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864935

Patterns of technological innovation in biotech

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864935

Diagnosing the decline in pharmaceutical R&D efficiency

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864935

Gene therapy finds its niche

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864935

Trends in risks associated with new drug development: success rates for investigational drugs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864935

Biotech boom prompts fears of bust.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864935

Lessons from 60 years of pharmaceutical innovation

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864935

Gold in the ivory tower: equity rewards of outlicensing

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864935

Prospects for productivity

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24358154

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Beyond the biotech IPO: a brave new world

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24358154

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0082195

1 reference

6 August 2017

0 references

1 reference

6 August 2017

1 reference

PubMed ID

24358154